BRPI0817270A2 - formas sólidas de 2-amino-3-(4-(2-amino-6((r)-1-1(4-cloro-2-(3-metil-1h-pirazol-1-il)) fenil-2,2,2-triflúor etóxi) pirimidin-4-il) fenil) propanoato de (s)-etila e processos de seu uso - Google Patents
formas sólidas de 2-amino-3-(4-(2-amino-6((r)-1-1(4-cloro-2-(3-metil-1h-pirazol-1-il)) fenil-2,2,2-triflúor etóxi) pirimidin-4-il) fenil) propanoato de (s)-etila e processos de seu usoInfo
- Publication number
- BRPI0817270A2 BRPI0817270A2 BRPI0817270A BRPI0817270A BRPI0817270A2 BR PI0817270 A2 BRPI0817270 A2 BR PI0817270A2 BR PI0817270 A BRPI0817270 A BR PI0817270A BR PI0817270 A BRPI0817270 A BR PI0817270A BR PI0817270 A2 BRPI0817270 A2 BR PI0817270A2
- Authority
- BR
- Brazil
- Prior art keywords
- phenyl
- amino
- propanoate
- pyrazol
- pyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97584607P | 2007-09-28 | 2007-09-28 | |
US60/975,846 | 2007-09-28 | ||
PCT/US2008/077594 WO2009042733A1 (en) | 2007-09-28 | 2008-09-25 | Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0817270A2 true BRPI0817270A2 (pt) | 2017-06-06 |
BRPI0817270B1 BRPI0817270B1 (pt) | 2022-02-08 |
Family
ID=39944300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0817270-6A BRPI0817270B1 (pt) | 2007-09-28 | 2008-09-25 | Compostos cristalinos de (s)-etil 2-amino-3-(4-(2-amino-6((r)-1-(4-cloro-2-(3-metil-1h-pirazol-1- il)) fenil2,2,2-triflúor etoxi) pirimidin-4-il) fenil) propanoato, sais, e seu processo preparação |
Country Status (26)
Country | Link |
---|---|
US (2) | US8193204B2 (pt) |
EP (1) | EP2203444B1 (pt) |
JP (1) | JP5717445B2 (pt) |
KR (1) | KR101644657B1 (pt) |
CN (1) | CN101809018B (pt) |
AR (1) | AR068558A1 (pt) |
AU (1) | AU2008304439B2 (pt) |
BR (1) | BRPI0817270B1 (pt) |
CA (1) | CA2700835C (pt) |
CL (1) | CL2008002880A1 (pt) |
CO (1) | CO6270325A2 (pt) |
DK (1) | DK2203444T3 (pt) |
EA (1) | EA017275B1 (pt) |
EC (1) | ECSP10010076A (pt) |
ES (1) | ES2431928T3 (pt) |
HK (1) | HK1145023A1 (pt) |
IL (1) | IL204373A (pt) |
MX (1) | MX2010003326A (pt) |
NZ (1) | NZ583808A (pt) |
PE (1) | PE20090742A1 (pt) |
PL (1) | PL2203444T3 (pt) |
PT (1) | PT2203444E (pt) |
TW (1) | TWI439457B (pt) |
UA (1) | UA102079C2 (pt) |
UY (1) | UY31364A1 (pt) |
WO (1) | WO2009042733A1 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103265495B (zh) | 2005-12-29 | 2016-11-16 | 莱西肯医药有限公司 | 多环氨基酸衍生物及其使用方法 |
US7897763B2 (en) | 2005-12-29 | 2011-03-01 | Lexicon Pharmaceuticals, Inc. | Process for the preparation of substituted phenylalanines |
US7855291B2 (en) * | 2005-12-29 | 2010-12-21 | Lexicon Pharmaceuticals, Inc. | Process for the preparation of substituted phenylalanines |
UA99270C2 (en) * | 2006-12-12 | 2012-08-10 | Лексикон Фармасьютикалз, Инк. | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
US8093291B2 (en) * | 2007-06-26 | 2012-01-10 | Lexicon Pharmaceuticals, Inc. | Methods of using and compositions comprising tryptophan hydroxylase inhibitors |
CA2697368C (en) * | 2007-08-24 | 2016-06-21 | Lexicon Pharmaceutical Inc. | Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
MX2010010799A (es) | 2008-03-31 | 2011-03-25 | Univ Columbia | Metodo de diagnostico, prevencion y tratamiento de las enfermedades de la masa osea. |
AU2010315190A1 (en) * | 2009-11-05 | 2012-05-10 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for the treatment of cancer |
TW201302754A (zh) * | 2010-11-05 | 2013-01-16 | Lexicon Pharmaceuticals Inc | 3-(4-(胺甲基)-1-(5-甲基-7h-吡咯[2,3-d]嘧啶-4-基)哌啶-4-甲醯胺基)苯基二甲基胺基甲酸酯之固態形式 |
PT2753306T (pt) * | 2011-10-17 | 2020-11-11 | Lexicon Pharmaceuticals Inc | Formas de dosagem sólidas de 2-amino-3-(4-(2-amino-6-((r)-1- (4-cloro-2-(3-metil-1h-pirazol-1-il)fenil)-2,2,2- trifluoroetoxi)pirimidin-4-il)fenil)propanoato de (s)-etilo |
EP3061761A1 (en) | 2015-02-24 | 2016-08-31 | Max-Delbrück-Centrum für Molekulare Medizin | Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same |
EP3275885A1 (en) | 2016-07-28 | 2018-01-31 | Max-Delbrück-Centrum für Molekulare Medizin | Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same |
EP3363798A1 (en) | 2017-02-20 | 2018-08-22 | Esteve Química, S.A. | Amorphous form of telotristat etiprate |
CN109180650A (zh) * | 2018-08-28 | 2019-01-11 | 湖南华腾制药有限公司 | 一种氘代色氨酸羟化酶抑制剂的晶型 |
WO2023192003A1 (en) | 2022-04-01 | 2023-10-05 | Tersera Therapeutics Llc | Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103265495B (zh) * | 2005-12-29 | 2016-11-16 | 莱西肯医药有限公司 | 多环氨基酸衍生物及其使用方法 |
UA99270C2 (en) | 2006-12-12 | 2012-08-10 | Лексикон Фармасьютикалз, Инк. | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
CA2697368C (en) | 2007-08-24 | 2016-06-21 | Lexicon Pharmaceutical Inc. | Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds |
TW200932729A (en) | 2007-10-08 | 2009-08-01 | Lexicon Pharmaceuticals Inc | Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
-
2008
- 2008-09-19 TW TW097136105A patent/TWI439457B/zh active
- 2008-09-25 UY UY31364A patent/UY31364A1/es not_active Application Discontinuation
- 2008-09-25 DK DK08834252.2T patent/DK2203444T3/da active
- 2008-09-25 UA UAA201005125A patent/UA102079C2/uk unknown
- 2008-09-25 BR BRPI0817270-6A patent/BRPI0817270B1/pt active IP Right Grant
- 2008-09-25 KR KR1020107006616A patent/KR101644657B1/ko active IP Right Grant
- 2008-09-25 MX MX2010003326A patent/MX2010003326A/es active IP Right Grant
- 2008-09-25 CN CN200880108684XA patent/CN101809018B/zh active Active
- 2008-09-25 US US12/237,455 patent/US8193204B2/en active Active
- 2008-09-25 PT PT88342522T patent/PT2203444E/pt unknown
- 2008-09-25 AR ARP080104181A patent/AR068558A1/es not_active Application Discontinuation
- 2008-09-25 JP JP2010527125A patent/JP5717445B2/ja active Active
- 2008-09-25 WO PCT/US2008/077594 patent/WO2009042733A1/en active Application Filing
- 2008-09-25 EA EA201070410A patent/EA017275B1/ru not_active IP Right Cessation
- 2008-09-25 PL PL08834252T patent/PL2203444T3/pl unknown
- 2008-09-25 ES ES08834252T patent/ES2431928T3/es active Active
- 2008-09-25 NZ NZ583808A patent/NZ583808A/en unknown
- 2008-09-25 AU AU2008304439A patent/AU2008304439B2/en active Active
- 2008-09-25 EP EP08834252.2A patent/EP2203444B1/en active Active
- 2008-09-25 CA CA2700835A patent/CA2700835C/en active Active
- 2008-09-26 CL CL2008002880A patent/CL2008002880A1/es unknown
- 2008-09-26 PE PE2008001677A patent/PE20090742A1/es not_active Application Discontinuation
-
2010
- 2010-03-09 IL IL204373A patent/IL204373A/en active IP Right Grant
- 2010-03-31 EC EC2010010076A patent/ECSP10010076A/es unknown
- 2010-04-28 CO CO10050287A patent/CO6270325A2/es not_active Application Discontinuation
- 2010-12-10 HK HK10111537.5A patent/HK1145023A1/xx unknown
-
2012
- 2012-06-01 US US13/486,103 patent/US8653094B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0817270A2 (pt) | formas sólidas de 2-amino-3-(4-(2-amino-6((r)-1-1(4-cloro-2-(3-metil-1h-pirazol-1-il)) fenil-2,2,2-triflúor etóxi) pirimidin-4-il) fenil) propanoato de (s)-etila e processos de seu uso | |
CY2015016I2 (el) | Αναστολεις της κινασης τυροσινης του bruton | |
BRPI0924183A2 (pt) | inibidores de proteína quinase, formas cristalinas, formulações farmacêuticas e uso | |
BRPI0911688A2 (pt) | "compostos de pirimidina, composições e métodos de uso" | |
BRPI0810523A2 (pt) | Derivado heterocíclico de 5 membros e uso do mesmo para propósitos médicos. | |
DK1973910T3 (da) | Pyrrolo[3,2-c]pyridin-4-on-2-indolinon-proteinkinaseinhibitorer | |
ATE514695T1 (de) | Pyrido(2,3-d)pyrimidinonverbindungen und ihre verwendung als pi3-inhibitoren | |
NL2000323A1 (nl) | Pyrimidine-derivaten. | |
BRPI0812563A2 (pt) | Metabólitos do inibidor de janus quinase de (r)-3-(4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)-3 ciclopentilpropanonitrila | |
BRPI0810086A2 (pt) | inibidores de tirosina quinase de bruton | |
BRPI0920598A2 (pt) | formas sólidas de n-(4(7-azabiciclo[2.2.1]heptan-7-il)-2-(triflúor-metil)fenil)-4-oxo-5-(triflúor-metil)-1,4-di-hidroquinolina-3-carboxamida | |
EP2099457A4 (en) | CYTOSCELETACTIVE RHO-KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | |
ATE512960T1 (de) | Pyrimidinderivate | |
DE602006019852D1 (de) | Verriegelungsspannfutter | |
DK1928427T3 (da) | Hidtil ukendt dosisformulering | |
DK2041093T3 (da) | Til behandling af GPR38-receptor medierede sygdomme anvendelige piperazinylderivativer | |
DE502006007133D1 (de) | Metall-keramik-substrat | |
BRPI0813457A2 (pt) | Composto de organoenxofre contendo halogênio e uso do mesmo | |
CU20090141A7 (es) | Compuestos 2-amino pirimidina | |
BRPI0808246A2 (pt) | "fralda descartável". | |
DK2035385T3 (da) | Inhibitorer af akt (proteinkinase B) | |
BRPI0808172A2 (pt) | Compostos heterocíclicos, composições compreendendo-os e métodos de seu uso. | |
BRPI0913175A2 (pt) | artigo antibalístico, e, uso do mesmo. | |
BRPI0822239A2 (pt) | Composto de pirazolo[1,5-a] pirimidina | |
ZA201002214B (en) | 3-methyl-2-((2s)-2-(4-(3-methyl-l,2,4-0xadiazol-5-yl)phenyl)morpholino)-6-(pyrimidin-4-yl)pyrimidin-4(3h)-one as tau protein kinase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: TERSERA THERAPEUTICS LLC (US) |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/09/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |